Biosimilar drugs could generate $38.4 billion in savings over five years
Are you Britain’s next super-matcher? You can take a test to find out
10 January 2022Who gives consent for treatment when a person with stroke cannot?
10 January 2022Biosimilar drugs could generate $38.4 billion in savings over five years
Biosimilar drugs could drive down prices for expensive medicines used to treat illnesses such as cancer and rheumatoid arthritis, with savings estimated to be $38.4 billion or 5.9% of projected total U.S. spending on biologics from 2021 to 2025, according to a new RAND Corporation study.
